Healthcare provider profile · identity verified

Julia Ratner, M.D.

Internal Medicine · VERNON HILLS, IL · NPI 1841446853

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	507	154
Amlodipine Besylate	Amlodipine Besylate	424	121
Levothyroxine Sodium	Levothyroxine Sodium	318	87
Gabapentin	Gabapentin	187	45
Omeprazole	Omeprazole	182	50
Losartan Potassium	Losartan Potassium	177	53
Metoprolol Succinate	Metoprolol Succinate	176	55
Hydrochlorothiazide	Hydrochlorothiazide	168	53
Rosuvastatin Calcium	Rosuvastatin Calcium	153	47
Pantoprazole Sodium	Pantoprazole Sodium	146	41
Lisinopril	Lisinopril	127	41
Simvastatin	Simvastatin	127	30
Sertraline Hcl	Sertraline Hcl	117	27
Pravastatin Sodium	Pravastatin Sodium	105	31
Escitalopram Oxalate	Escitalopram Oxalate	102	28
Trazodone Hcl	Trazodone Hcl	99	22
Metformin Hcl	Metformin Hcl	95	27
Eliquis	Apixaban	92	16
Irbesartan	Irbesartan	91	22
Alendronate Sodium	Alendronate Sodium	90	21
Alprazolam	Alprazolam	90	22
Duloxetine Hcl	Duloxetine Hcl	85	19
Famotidine	Famotidine	82	23
Tramadol Hcl	Tramadol Hcl	78	19
Montelukast Sodium	Montelukast Sodium	77	21
Azelastine Hcl	Azelastine Hcl	76	32
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	75	20
Zolpidem Tartrate	Zolpidem Tartrate	71	14
Meloxicam	Meloxicam	68	22
Synthroid	Levothyroxine Sodium	63	20
Metformin Hcl Er	Metformin Hcl	62	24
Paroxetine Hcl	Paroxetine Hcl	61	suppressed
Furosemide	Furosemide	60	20
Ipratropium Bromide	Ipratropium Bromide	59	19
Valsartan	Valsartan	58	21
Bupropion Xl	Bupropion Hcl	56	17
Carvedilol	Carvedilol	55	16
Januvia	Sitagliptin Phosphate	53	12
Fluticasone Propionate	Fluticasone Propionate	52	18
Clonazepam	Clonazepam	50	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	14
Metoprolol Tartrate	Metoprolol Tartrate	49	11
Ezetimibe	Ezetimibe	48	14
Torsemide	Torsemide	41	12
Glimepiride	Glimepiride	40	13
Myrbetriq	Mirabegron	39	suppressed
Ozempic	Semaglutide	39	suppressed
Atenolol	Atenolol	38	suppressed
Mirtazapine	Mirtazapine	38	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	37	24
Sucralfate	Sucralfate	37	suppressed
Benazepril Hcl	Benazepril Hcl	34	suppressed
Solifenacin Succinate	Solifenacin Succinate	34	suppressed
Spironolactone	Spironolactone	33	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	33	suppressed
Mounjaro	Tirzepatide	31	suppressed
Ramipril	Ramipril	31	suppressed
Lidocaine	Lidocaine	30	suppressed
Nystatin	Nystatin	29	suppressed
Tradjenta	Linagliptin	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Rizatriptan	Rizatriptan Benzoate	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Allopurinol	Allopurinol	25	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	12
Adderall	Dextroamphetamine/Amphetamine	22	suppressed
Jardiance	Empagliflozin	22	suppressed
Telmisartan	Telmisartan	22	suppressed
Azithromycin	Azithromycin	21	21
Doxycycline Hyclate	Doxycycline Hyclate	21	17
Memantine Hcl	Memantine Hcl	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Potassium Chloride	Potassium Chloride	18	suppressed
Diazepam	Diazepam	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Xifaxan	Rifaximin	16	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	12
Xarelto	Rivaroxaban	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Cephalexin	Cephalexin	14	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Cefpodoxime Proxetil	Cefpodoxime Proxetil	13	12
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Nucynta	Tapentadol Hcl	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Prednisone	Prednisone	12	suppressed
Topiramate	Topiramate	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Clopidogrel	Clopidogrel Bisulfate	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error